Search Complied AI

Laws and sections by number or title, due dates, pages, and updates.

Revision in Specifications, Brand Name… — 10 Nov 2026 | ESIC circular · Complied AI

Complied AI

Updates Laws Calendar Guides

Updates
/
ESIC
/
Circulars
/
Revision in Specifications, Brand Name…

ESIC circulars

ESICCircular10 Nov 2026

Revision in Specifications, Brand Name and Rate/Unit of approved item no.2228 under DGESIC RC 156 of M/s. Zydus Lifesciences Limited for Inactivated Influenza Vaccine from Tetravalent (Vaxiflu-4™) to Trivalent (Vaxiflu™) -reg

Complied AI

Statutory updates. Official sources. Acts & Rules.

Built for Indian compliance professionals.

hello@compliedai.com

SourceOfficial source (opens esic.gov.in in a new tab)

We could not read this circular cleanly. Open it on esic.gov.in.

Official source (opens esic.gov.in in a new tab)

Save it to come back when a readable version is added.

Source details

Source: Employees' State Insurance Corporation
Type: circular
Published by source: 10 Nov 2026
Coverage area: labour

Other ESIC records on the same subject or citing the same provisions.

Downward Rate Revision for Item No.2221 under DGESIC RC-156 of approved pharmaceutical firm M/s. Sandoz Private Limited-reg01 Jun 2026circular

Earlier and later ESIC circulars

All ESIC circulars

Earlier·10 Nov 2026Continuation of Administrative Ministerial and Non-Ministerial Posts Later·10 Nov 2026Superannuation of Group ‘A’ & ‘B’ officers (nonmedical) from the service of ESIC during the period between 01.01.2027 to 31.12.2027

Official record

esic.gov.in

Official source

On this page

Source details
Related
Earlier and later

Browse

Updates
Weekly summaries
Sources
Laws
Guides
Atom feed

Platform

AI compliance platform
Compliance calendar

Company

About
Why we built this
Editorial standards
Roadmap
What's new
Work with us
Contact

Support

Help
FAQ
Newsletter
Security

Legal

Privacy
Terms
Disclaimer
Cookies
Refunds

Search Complied AI

Revision in Specifications, Brand Name and Rate/Unit of approved item no.2228 under DGESIC RC 156 of M/s. Zydus Lifesciences Limited for Inactivated Influenza Vaccine from Tetravalent (Vaxiflu-4™) to Trivalent (Vaxiflu™) -reg

Source details

Related